UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in critical patients with chronic heart failure

ESC Heart Failure, 2022-04, Vol.9 (2), p.1360-1369

2022

Volltextzugriff (PDF)

Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response

Genome medicine, 2024-04, Vol.16 (1), p.47-17, Article 47

2024

Volltextzugriff (PDF)

Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways

Drugs in R&D, 2023-12, Vol.23 (4), p.439-451

2023

Volltextzugriff (PDF)

Anlotinib exerts potent antileukemic activities in Ph chromosome negative and positive B-cell acute lymphoblastic leukemia via perturbation of PI3K/AKT/mTOR pathway

Translational oncology, 2022-11, Vol.25, p.101516-101516, Article 101516

2022

Volltextzugriff (PDF)

MiR‐3130‐5p is an intermediate modulator of 2q33 and influences the invasiveness of lung adenocarcinoma by targeting NDUFS1

Cancer medicine (Malden, MA), 2021-06, Vol.10 (11), p.3700-3714

2021

Volltextzugriff (PDF)

Comparison between sentiments of people from affected and non-affected regions after the flood

Geomatics, natural hazards and risk, 2021-01, Vol.12 (1), p.3346-3357

2021

Volltextzugriff (PDF)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma

Frontiers in oncology, 2021-12, Vol.11, p.780118-780118

2021

Volltextzugriff (PDF)

Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways

Experimental hematology & oncology, 2022-04, Vol.11 (1), p.23-23, Article 23

2022

Volltextzugriff (PDF)

Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study

Biomarker research, 2023-02, Vol.11 (1), p.16-13, Article 16

2023

Volltextzugriff (PDF)

Therapeutic Interaction of Apatinib and Chidamide in T-Cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis

Journal of personalized medicine, 2021-09, Vol.11 (10), p.977

2021

Volltextzugriff (PDF)

Anlotinib Shows Potent Antileukemia Effects in B-Cell Acute Lymphocytic Leukemia through the Blockage of Angiogenic Related Pathways

Blood, 2020-11, Vol.136 (Supplement 1), p.49-49

2020

Volltextzugriff (PDF)

An Azaindole-Based Small Molecule Hzx-02-059 Induces Methuosis in B-Cell Acute Lymphoblastic Leukemia through the PI3K/AKT Axis

Blood, 2020-11, Vol.136 (Supplement 1), p.9-9

2020

Volltextzugriff (PDF)

Low-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia

Leukemia, 2020-07, Vol.34 (7), p.1816-1827

2020

Volltextzugriff (PDF)

The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data

International journal of environmental research and public health, 2022-04, Vol.19 (9), p.5267

2022

Volltextzugriff (PDF)

Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia

Leukemia, 2019-04, Vol.33 (4), p.931-944

2019

Volltextzugriff (PDF)

Stratification and therapeutic potential of ELL in cytogenetic normal acute myeloid leukemia

Gene, 2023-03, Vol.856, p.147110-147110, Article 147110

2023

Volltextzugriff (PDF)

Epigenome-augmented eQTL-hotspots reveal genome-wide transcriptional programs in 36 human tissues

Briefings in bioinformatics, 2024-03, Vol.25 (3)

2024

Volltextzugriff (PDF)

Combination of CS2164 and Venetoclax Shows Synergistic Antitumor Effect in High-Grade B-Cell Lymphomas with ConcomitantMYCandBCL2Rearrangements

Blood, 2020-11, Vol.136, p.41-41

2020

Volltextzugriff (PDF)

Combination of CS2164 and Venetoclax Shows Synergistic Antitumor Effect in High-Grade B-Cell Lymphomas with Concomitant MYC and BCL2 Rearrangements

Blood, 2020-11, Vol.136 (Supplement 1), p.41-41

2020

Volltextzugriff (PDF)

CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models

European journal of pharmacology, 2019-06, Vol.853, p.193-200

2019

Volltextzugriff (PDF)

Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation

European journal of pharmacology, 2021-12, Vol.913, p.174633-174633, Article 174633

2021

Volltextzugriff (PDF)

Residual TP53 Mutation Contributes to Chemoresistance through Clonal Expansion in Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.2731-2731

2019

Volltextzugriff (PDF)

Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Cancer research (Chicago, Ill.), 2021-08, Vol.81 (16), p.4205-4217

2021

Volltextzugriff (PDF)

Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway

European journal of pharmacology, 2019-01, Vol.843, p.145-153

2019

Volltextzugriff (PDF)

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.3048-3048

2023

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(108)
Humans
(49)
Technology
(41)
Physical Sciences
(32)
Female
(19)
Orthopedics
(19)
Materials Science
(18)
Animals
(17)
Engineering
(16)
Oncology
(16)
Physics
(16)
Mice
(14)
Chemistry
(13)
Male
(13)
Materials Science, Multidisciplinary
(13)
Sport Sciences
(13)
Surgery
(13)
Patients
(12)
Physics, Applied
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in critical patients with chronic heart failure

Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response

Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways

Anlotinib exerts potent antileukemic activities in Ph chromosome negative and positive B-cell acute lymphoblastic leukemia via perturbation of PI3K/AKT/mTOR pathway

MiR‐3130‐5p is an intermediate modulator of 2q33 and influences the invasiveness of lung adenocarcinoma by targeting NDUFS1

Comparison between sentiments of people from affected and non-affected regions after the flood

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma

Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways

Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study

Therapeutic Interaction of Apatinib and Chidamide in T-Cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis

Anlotinib Shows Potent Antileukemia Effects in B-Cell Acute Lymphocytic Leukemia through the Blockage of Angiogenic Related Pathways

An Azaindole-Based Small Molecule Hzx-02-059 Induces Methuosis in B-Cell Acute Lymphoblastic Leukemia through the PI3K/AKT Axis

Low-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia

The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data

Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia

Stratification and therapeutic potential of ELL in cytogenetic normal acute myeloid leukemia

Epigenome-augmented eQTL-hotspots reveal genome-wide transcriptional programs in 36 human tissues

Combination of CS2164 and Venetoclax Shows Synergistic Antitumor Effect in High-Grade B-Cell Lymphomas with ConcomitantMYCandBCL2Rearrangements

Combination of CS2164 and Venetoclax Shows Synergistic Antitumor Effect in High-Grade B-Cell Lymphomas with Concomitant MYC and BCL2 Rearrangements

CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models

Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation

Residual TP53 Mutation Contributes to Chemoresistance through Clonal Expansion in Acute Myeloid Leukemia

Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Suchergebnisse filtern